Accreditation Statement and Credit Designation
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the International Society of Paediatric Oncology (SIOP). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Centre (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Professional Development
The event has been submitted for Nursing Continuing Professional Development accreditation. Further information will be provided in due course.
Target Audience
The target audience for this activity includes pediatric oncologists, pediatric hematologist-oncologists, pediatric surgeons and surgical oncologists, radiation oncologists, pediatric oncology nurses, pharmacists, pathologists, radiologists, rehabilitation specialists, psychologists, psychosocial oncology professionals, survivorship specialists, researchers, and other healthcare professionals involved in the multidisciplinary care of children, adolescents, and young adults with cancer.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
- Evaluate the clinical applicability, strengths, and limitations of emerging AI and digital technologies in pediatric oncology care.
- Integrate molecular, genomic, and clinical evidence into treatment selection and risk-adapted management strategies.
- Apply evidence-based communication and supportive care strategies to address the physical, emotional, and psychosocial needs of pediatric oncology patients and families.
- Compare and apply strategies that improve access, quality, and equity in pediatric cancer care across diverse practice settings.
Faculty and Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners’ policies. Others involved in the planning of this activity have no relevant financial relationships.
- Disclosure information will be available at least one week before the conference.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Commitment to the Highest Standards in CME/CPD
Kenes Group is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by:
Championing best practice in CME/CPD
Maintaining and improving standards
Mentoring and educating
Working in collaboration with critical stakeholders
Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.